Full Description
This book is a comprehensive guide to pediatric psychopharmacology, detailing medications used to treat a wide variety of childhood and adolescent mental illnesses. Childhood and adolescence represent critically important life stages in cognitive, social, and emotional development. Unfortunately, the prevalence of mental illness has been growing over the last several decades, especially among children. It is estimated that suicide is the second most common cause of death among adolescents and young adults in the United States. A crucial component of evidence-based mental health treatment of youth consists of careful, sophisticated, and compassionate medication treatment.
This guide is divided into 18 chapters, with most covering the medications used to treat a specific disorder or group of disorders. Chapters comprehensively cover each medication's history, FDA indication status and context, representation in the media, mechanism, extent of usage and research, and quality of evidence supporting its efficacy and safety. Chapters also cover approaches clinicians can use to discuss medications with patients—including alternative treatment options and integrating patient-level variables when choosing a medication. This book focuses on understanding patient and family perspectives on medication with suggested clinician responses to better communicate about prescription management. Chapters also include tables and figures, list resources and guidelines, and discuss controversies in the media.
All prescribers to children and adolescents will find Pediatric Psychopharmacology Evidence to be a timely, comprehensive, and compassionate guide to the pharmacological treatment of young patients with mental illness.
Contents
INTRODUCTION TO THE FUNDAMENTALS OF PEDIATRIC PSYCHOPHARMACOLOGY.- Part 1 TRANSDIAGNOSTIC TOPICS.- PEDIATRIC PSYCHOPHARMACOLOGY INTEGRATION WITH FAMILY THERAPY.- RATIONALE FOR INTEGRATING PSYCHODYNAMIC THEORY INTO PEDIATRIC PSYCHOPHARMACOLOGY.- Ensuring Appropriate Use of Psychotropic Medications in Pediatrics - Best Practices in Medication Discontinuation (Deprescribing).- PSYCHOPHARMACOLOGY OF "AS-NEEDED" MEDICATIONS (PRNS) FOR PEDIATRIC AGITATION IN INPATIENT AND EMERGENCY SETTINGS.- OVER THE COUNTER MEDICATIONS AND NUTRITIONAL SUPPLEMENTS IN CHILD PSYCHIATRY.- Part 2 NEURODEVELOPMENTAL AND IMPULSIVE-COMPULSIVE SPECTRUM DISORDERS.- PSYCHOPHARMACOLOGY FOR AUTISM AND NEURODEVELOPMENTAL DISORDERS.- Part 3 Anxiety Spectrum Disorders.- PSYCHOPHARMACOLOGY FOR PEDIATRIC ADHD.- PSYCHOPHARMACOLOGY FOR PEDIATRIC TICS AND TOURETTE'S DISORDER.- PSYCHOPHARMACOLOGY FOR PEDIATRIC OCD AND RELATED DISORDERS.- Adolescent Substance Use Disorders.- Psychopharmacology for Pediatric Eating Disorders.- PSYCHOPHARMACOLOGY FOR PEDIATRIC AGGRESSION.- Part 4 ANXIETY SPECTRUM DISORDERS.- Psychopharmacology For Pediatric Anxiety Disorders.- PSYCHOPHARMACOLOGY FOR PEDIATRIC PTSD.- Part 5 MOOD AND PSYCHOSIS SPECTRUM DISORDERS.- Psychopharmacology for Pediatric Depressive Disorders.- PSYCHOPHARMACOLOGY FOR PEDIATRIC BIPOLAR DISORDER.- PSYCHOPHARMACOLOGY FOR PEDIATRIC SCHIZOPHRENIA AND PSYCHOTIC DISORDERS.- Part 6 SLEEP DISORDERS.- PRACTICAL PSYCHOPHARMACOLOGY OF PEDIATRIC SLEEP DISORDERS.
